Topotecan
- Product NDC
- 66758-051
- 11-digit product format
- 667580051
- Labeler code
- 66758
- Product ID
- 66758-051_6bc88223-4de9-4ff7-b59f-e479c1fce600
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Topotecan
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Sandoz Inc
- Application
- NDA200199
- Marketing category
- NDA
- Marketing start
- 2011-02-25
- Marketing end
- 0000-00-00
- Substance
- TOPOTECAN HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 66758-051-01 | 2019-11-19 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |
| 66758-051-03 | 2019-11-19 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |
| 66758-051-05 | 2019-11-19 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |
| 66758-051-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |
| 66758-051-03 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |
| 66758-051-05 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d871-8e05-e053-dbdaa90a074a | 6bc88223-4de9-4ff7-b59f-e479c1fce600 |